The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The updated guidelines recommend SGLT2 inhibitors as first-line therapy for many cats with diabetes and detail patient selection, β-hydroxybutyrate monitoring, diet, and when to switch to insulin. "My ...

Builds on recent FDA approval (May 29, 2026) of Afrezza for use in children and adolescents aged 6 and older living with type 1 and type 2 ...

The American Diabetes Association (ADA) recently released their 2025 Standards of Care, which – for the first time – includes recommendations for CGM use in type 2 diabetes, the use of GLP-1 drugs for ...

Here are some of the top technology highlights covered at the American Diabetes Association's 2026 scientific conference in New Orleans. Broadening access to diabetes technology and developing new ...

The biggest names in diabetes tech gathered in New Orleans last weekend for the American Diabetes Association’s 86th Scientific Sessions (ADA 2026). Clinical findings supporting next-generation ...

Introduction Adult-onset type 1 diabetes (T1D) is often misclassified as type 2 diabetes (T2D), resulting in delayed treatment, missed opportunities for referrals to specialists and increased risk of ...

There is no cure for type 1 diabetes, in which the body attacks insulin-producing cells, leading to high blood sugar. People with type 1 diabetes need to monitor their blood sugar and use insulin ...

Patients experiencing life-threatening diabetic ketoacidosis (DKA) require quick action, diligent care and close monitoring ...

At AANP 2026, clinicians share how NPs are on the front lines of asthma management, necessitating a full understanding of the ...

NORTHRIDGE, Calif., June 3, 2026 /CNW/ -- MiniMed (NASDAQ: MMED), a global leader in diabetes technology, today announced an expanded agreement with Abbott to collaborate on commercializing dual ...

BACKGROUND: Undertreatment and delayed treatment of aortic stenosis (AS) are common, both of which are associated with increased mortality. Historically, assessment of quality for AS care has focused ...